Cancer

Tasquinimod improves radiographic PFS in mCRPC

(HealthDay)—For chemotherapy-naive men with metastatic castration-resistant prostate cancer (mCRPC), tasquinimod is associated with improved radiographic progression-free survival (rPFS), according to a phase III study ...

Jun 16, 2016
popularity0 comments 0

Fighting resistant blood cancer cells

Chronic myeloid leukemia (CML) develops through chromosomal alterations in blood-forming cells of the bone marrow and usually occurs in older persons. Around 20 percent of adults diagnosed with leukemia suffer from this type ...

Jun 20, 2016
popularity5 comments 0